Q: Pat: BioLineRx is an Israeli company working in several health areas. What’s your take on the company, Pat? Thanks.

A: BioLineRx (ADR), $1.12, symbol BLRX on Nasdaq (ADRs outstanding: 104.1 million; Market cap: $118.0 million; www.biolinerx.com), is a clinical-stage biopharmaceutical company that aims to identify, license and develop promising therapeutic medications and treatments. It’s based in Israel.

The company licenses the new drug compounds developed… Read More

Q: Hi Pat: What do you think about Deutsche Bank. When is the right time to buy? Also, I do not understand the rights issue it is offering. Are the rights separate shares? Thank you very much for your insights.

A: Deutsche Bank AG (ADR), $18.52, symbol DB on New York (ADRs outstanding: 2.1 billion; Market cap: $35.1 billion; www.db.com), is a German global banking and financial services company with its headquarters in Frankfurt.
Deutsche Bank has been among the worst performers in the European banking… Read More